Trial intelligence / Profile preview

Pegylated Interferon Plus Ribavirin in Older Patients With Chronic Hepatitis C

NCT00629824Phase 4Completed

Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Start
Feb 2007
Primary completion
Apr 2009
Modality
rProtein (Recombinant Protein), Biologic
Countries
1
01

Overview

A Phase 4 trial of peginterferon alfa-2a in hepatitis C (HCV), sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Started Feb 2007; status: completed.

02

Drugs

peginterferon alfa-2a
03

Conditions

hepatitis C (HCV)

Beyond the preview

Go deeper on NCT00629824.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00629824.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call